MSCI (MSCI) shares moved after the company reported strong first quarter results, with broad-based strength across Index, Analytics and asset-based fee businesses supporting higher interest in the stock.

The strong first quarter update appears to have reset sentiment, with the stock up 1.07% on a 1-day share price return and 8.17% on a 90-day share price return, while the 1-year total shareholder return of 6.82% and 5-year total shareholder return of 32.88% point to steadier long term compounding.

If this kind of steady compounding appeals to you, it may be worth broadening your watchlist to see what else stands out in our 20 top founder-led companies

With MSCI trading around US$588.55 per share and sitting at a 6.96% discount to one estimate of intrinsic value, plus a 16.46% gap to the average analyst target, should you see upside here or assume the market is already pricing in future growth?

Most Popular Narrative: 120.4% Overvalued

According to a widely followed narrative from Esteban, MSCI's fair value of $267 sits well below the last close of $588.55, setting up a clear valuation gap for investors to weigh.

MSCI is a Wide Moat compounding machine whose index benchmarks serve as the institutional standard for $16.5 trillion in global AUM, generating 75%+ recurring revenue at 93-95% retention rates and approximately 50% FCF margins. The investment thesis rests on three durable pillars: (1) permanent switching costs in the Index segment, where fund mandate rewrites, LP notifications, and derivative contract renegotiations make benchmark migration prohibitively costly for all but the most determined sponsors; (2) secular tailwinds from the continued growth of passive investing and the institutionalization of private markets, which expand MSCI's AUM-linked revenue with zero incremental cost; and (3) an emerging private assets franchise replicating the Index playbook in a $10 trillion+ private equity and credit market that currently lacks institutional-grade benchmarks.

Curious how those switching costs, recurring revenues and private asset ambitions shape that valuation gap? The narrative leans heavily on margins, capital efficiency and a long runway of contracted growth assumptions. The full story connects those ingredients into a single fair value number.

Result: Fair Value of $267 (OVERVALUED)

However, these assumptions can be challenged if passive flows slow or if regulators and asset owners push harder for alternative benchmarks and pricing models.

Another View: Earnings Multiple Sends a Different Signal

Esteban's $267 fair value points to an expensive stock, but the current P/E of 32.5x tells a more mixed story. It sits below the US Capital Markets industry at 40.1x, yet above the peer average of 28.7x and the fair ratio of 16.5x. The key question is whether this reflects a premium worth paying or valuation risk building.

For a closer look at how these P/E gaps might matter for your own checklist, it is worth reviewing the valuation breakdown in more detail. This includes how the fair ratio could become the anchor the market moves toward over time, particularly if sentiment changes or growth expectations shift. See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With sentiment divided between premium risks and quality rewards, this is the moment to look under the hood yourself and move quickly. To see how those trade offs compare, review the 3 key rewards and 2 important warning signs

Looking for more investment ideas?

If you stop with just one stock, you could miss opportunities that fit your goals even better, so put the Simply Wall Street Screener to work for you.

• Stress test your income plan by focusing on companies with higher yields that still look robust, using our 10 dividend fortresses
• Zero in on quality at a price that may look reasonable by filtering for companies in our 49 high quality undervalued stocks
• Stack the odds toward resilience by scanning companies with stronger finances and fundamentals via the solid balance sheet and fundamentals stocks screener (46 results)

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.